Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasmatic fibronectin in malignancies.

P Gallurt1, P Rodriguez, A Lorenzo

  • 1Department of Medicine, Faculty of Medicine, University of Cadiz, Spain.

The International Journal of Biological Markers
|October 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative study of flexible 3D printing materials for clinical application as boluses in radiotherapy.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2025
Same author

Skin lesions by Scedosporium apiospermum and Nocardia pulmonary infection in an oncologic patient: a case report.

BMC infectious diseases·2023
Same author

Deep learning of renal scans in children with antenatal hydronephrosis.

Journal of pediatric urology·2023
Same author

Carbon and nitrogen isotopic similarity between the endangered Darwin's fox (<i>Lycalopex fulvipes</i>) and sympatric free-ranging dogs in Chiloé Island, Chile.

Isotopes in environmental and health studies·2022
Same author

Oxytocin-Cholinergic Central Interaction: Implications for Non-Social Memory Formation.

Neuroscience·2022
Same author

A serosurvey for spotted fever group Rickettsia and Coxiella burnetii antibodies in rural dogs and foxes, Chile.

Comparative immunology, microbiology and infectious diseases·2022
Same journal

The diagnostic and predictive value of miR-145-3p in gastric cancer and its regulation of gastric cancer progression via targeting CREB1.

The International journal of biological markers·2026
Same journal

PFKP: A biomarker for prognosis, response to treatment and immune function of breast cancer.

The International journal of biological markers·2026
Same journal

Luminex assay of plasma IL-6, TNF-α, leptin, and adiponectin: Impact of anticoagulants, single-well analysis, and freeze-thaw stability.

The International journal of biological markers·2026
Same journal

Expression of concern: "RIPK4 is Downregulated in Poorly Differentiated Tongue Cancer and is Associated with Migration/Invasion and Cisplatin-Induced Apoptosis".

The International journal of biological markers·2026
Same journal

Association of NF-kappaBIA rs696 gene polymorphism with breast cancer risk in Bangladeshi women: A case-control study.

The International journal of biological markers·2026
Same journal

Circulating tumor cells and tumor-derived cell-free DNA in cancer management: Clinical evidence, limitations, and future directions.

The International journal of biological markers·2026
See all related articles

Plasmatic fibronectin levels show potential as a cancer biomarker. While overall levels didn't differ, breast cancer patients had higher fibronectin, and head and neck cancer patients had lower levels.

Area of Science:

  • Oncology
  • Biochemistry
  • Immunology

Background:

  • Unspecific opsonins, like fibronectin, may influence tumor progression.
  • Altered fibronectin levels are being investigated as potential biological markers for cancer diagnosis.

Purpose of the Study:

  • To evaluate the diagnostic significance of plasmatic fibronectin levels in cancer patients.
  • To determine if fibronectin serves as a useful biomarker for specific tumor types.

Main Methods:

  • Comparison of plasmatic fibronectin levels between a control group and tumor patients.
  • Analysis of fibronectin levels based on tumor location.
  • Receiver Operating Characteristic (ROC) curve analysis to assess diagnostic accuracy.

Main Results:

Related Experiment Videos

  • No significant difference in overall plasmatic fibronectin levels between control and tumor patient groups.
  • Significant increase in fibronectin levels observed in breast cancer patients (31.83 +/- 3.83 mg/dl).
  • Significant decrease in fibronectin levels observed in squamous cell carcinoma of the head and neck (9.56 +/- 1.68 mg/dl).

Conclusions:

  • Plasmatic fibronectin may serve as a valuable biomarker for specific cancer types, such as breast cancer and head and neck cancers.
  • The diagnostic utility of fibronectin as a cancer biomarker is supported by ROC curve analysis.
  • Further research is warranted to elucidate the role of fibronectin in different oncological contexts.